Abstract
Filgotinib (GS-6034, formerly GLPG0634; Jyseleca (R)) is an oral, preferential Janus kinase (JAK)-1 inhibitor. Preferential inhibition of JAK1 modulat......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
